Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioAtla (BCAB) Other financing activities (2025)

BioAtla (BCAB) has disclosed Other financing activities for 1 consecutive years, with $453000.0 as the latest value for Q4 2025.

  • For Q4 2025, Other financing activities changed N/A year-over-year to $453000.0; the TTM value through Dec 2025 reached $897000.0, changed N/A, while the annual FY2025 figure was $897000.0, N/A changed from the prior year.
  • Other financing activities hit $453000.0 in Q4 2025 for BioAtla, up from $78000.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $453000.0 in Q4 2025 and bottomed at $78000.0 in Q2 2025.